These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2078308)

  • 1. Learning deficits in aged rats pretreated chronically with barbital and tested late in abstinence: alleviation by tetrahydroaminoacridine.
    Mohammed AK; Wahlström G; Archer T; Nordberg A
    J Neural Transm Park Dis Dement Sect; 1990; 2(4):285-94. PubMed ID: 2078308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cholinesterase inhibitors on learning and memory in rats: a brief review with special reference to THA.
    Mohammed AH
    Acta Neurol Scand Suppl; 1993; 149():13-5. PubMed ID: 8128832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve growth factor (NGF) in rat brain following long-term barbital treatment: relation to convulsions and cognitive function.
    Wahlström G; Archer T; Lärkfors L
    Neurosci Lett; 1992 Mar; 137(1):65-8. PubMed ID: 1625820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of THA on hemicholinium-3-induced learning impairment is independent of serotonergic and noradrenergic systems.
    Hagan JJ; Jansen JH; Nefkens FE; de Boer T
    Psychopharmacology (Berl); 1990; 101(3):376-83. PubMed ID: 2362954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity to cholinergic drug treatments of aged rats with variable degrees of spatial memory impairment.
    Stemmelin J; Cassel JC; Will B; Kelche C
    Behav Brain Res; 1999 Jan; 98(1):53-66. PubMed ID: 10210522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of tetrahydroaminoacridine and physostigmine on scopolamine-induced free swim behavior in the rat.
    Dokla CP; Rydelek-Fitzgerald L
    Psychopharmacology (Berl); 1991; 103(2):240-3. PubMed ID: 2027924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tetrahydroaminoacridine, a cholinesterase inhibitor, on cognitive performance following experimental brain injury.
    Pike BR; Hamm RJ; Temple MD; Buck DL; Lyeth BG
    J Neurotrauma; 1997 Dec; 14(12):897-905. PubMed ID: 9475371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physostigmine and tetrahydroaminoacridine treatment of Alzheimer's disease.
    Gustafson L
    Acta Neurol Scand Suppl; 1993; 149(Rand):39-41. PubMed ID: 8128836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic response to tacrine (THA) and physostigmine in the aged rat brain.
    Bassant MH; Jazat-Poindessous F; Lamour Y
    J Cereb Blood Flow Metab; 1995 Nov; 15(6):1093-102. PubMed ID: 7593342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of THA and physostigmine on spatial navigation and avoidance performance in mecamylamine and PCPA-treated rats.
    Riekkinen M; Riekkinen P
    Exp Neurol; 1994 Jan; 125(1):111-8. PubMed ID: 8307118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired performance of rats in the Morris swim-maize test late in abstinence following long-term sodium barbital treatment.
    Mohammed AK; Wahlström G; Tiger G; Björklund PE; Stenström A; Magnusson O; Archer T; Fowler CJ; Nordberg A
    Drug Alcohol Depend; 1987 Nov; 20(3):203-12. PubMed ID: 3436253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tetrahydroaminoacridine on spatial navigation of nucleus-basalis- and frontal-cortex-lesioned rats.
    Riekkinen P; Riekkinen M; Sirviö J
    Pharmacol Biochem Behav; 1992 Mar; 41(3):637-41. PubMed ID: 1584845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct comparison of cognitive facilitation by physostigmine and tetrahydroaminoacridine in two primate models.
    Rupniak NM; Field MJ; Samson NA; Steventon MJ; Iversen SD
    Neurobiol Aging; 1990; 11(6):609-13. PubMed ID: 2280804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation of the effect of tacrine and physostigmine on spatial working memory deficits in the olfactory bulbectomised rat.
    Hallam KT; Horgan JE; McGrath C; Norman TR
    Behav Brain Res; 2004 Aug; 153(2):481-6. PubMed ID: 15265646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrahydroaminoacridine and D-cycloserine fail to alleviate the water maze spatial navigation defect induced by hippocampal inactivation.
    Riekkinen P; Ikonen S; Aura J; Riekkinen M
    Eur J Pharmacol; 1999 Jan; 366(1):13-8. PubMed ID: 10064146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal by tetrahydroaminoacridine of scopolamine-induced memory and performance deficits in rats.
    Murray TK; Cross AJ; Green AR
    Psychopharmacology (Berl); 1991; 105(1):134-6. PubMed ID: 1745706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose tetrahydroaminoacridine (THA) improves cognitive function but does not affect brain acetylcholine in rats.
    Hodges H; Ribeiro AM; Gray JA; Marchbanks RM
    Pharmacol Biochem Behav; 1990 Jun; 36(2):291-8. PubMed ID: 2356203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrahydroaminoacridine and physostigmine increase cerebral glucose utilization in specific cortical and subcortical regions in the rat.
    Bassant MH; Jazat F; Lamour Y
    J Cereb Blood Flow Metab; 1993 Sep; 13(5):855-64. PubMed ID: 8360291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple effects of tetrahydroaminoacridine on the cholinergic system: biochemical and behavioural aspects.
    Adem A; Mohammed AK; Winblad B
    J Neural Transm Park Dis Dement Sect; 1990; 2(2):113-28. PubMed ID: 2222779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tetrahydroaminoacridine (tacrine) derivatives and physostigmine in convulsions induced by pentylenetetrazol.
    Herink J; Koupilová M; Hrdina V
    Act Nerv Super (Praha); 1989 Dec; 31(4):303-5. PubMed ID: 2638124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.